Although type-2 diabetes (T2D) has been reported to increase the risk of cognitive dysfunction and dementia, the underlying mechanisms remain unclear. Dementia-like pathology is attributed to the accumulation of cellular prion protein (PrP c ) which plays a role in cognitive dysfunction. However, its involvement and regulation in diabetic dementia-like pathology is not well understood. Using T2D db/db (leptin receptor knockout) mice subjected to object recognition and Y-maze behavioral tests, we determined that short-term memory was compromised and that the mice displayed abrupt spontaneous behaviour compared to db/m control mice. MicroRNA analysis using qRT 2 -PCR array demonstrated a significant reduction in the transcript expression of microRNA-146a (miR146a) in the brain of T2D db/db mice as compared to db/m controls. The sequence matching tools validated the binding of miR-146a to a conserved domain of the PrP c gene. Administration of mouse brain endothelial cell-derived exosomes (BECDEs) loaded with miR-146a into the brain's ventricle of T2D db/db mice attenuated brain PrP c levels and restored short-term memory function though not significant. Also, we observed hyperphosphorylation of tau through decreased expression of glycogen synthase kinase-3 in T2D db/db brains that regulates microtubule organization and memory function. We conclude that underexpression of miR-146a upregulates PrP c production in T2D db/db mice and the delivery of BECDEs loaded with a miR-146a can down regulate PrP c levels and restore short term memory function up to a certain extent.
Introduction
Type-2 diabetes (T2D) describes a group of metabolic disorders that increases the risk factor for various cerebrovascular diseases and dementia (Haan et al., 2003; Pendlebury and Rothwell, 2009; Reitz et al., 2011) . Dementia comprises several symptoms which include progressive loss of memory and disturbance in normal behaviour (Ritchie and Lovestone, 2002) . The global prevalence of dementia is estimated to be 24 million people worldwide and the affected population is predicted to be doubled every 20 years, putting a costly burden of the disease globally (Ferri et al., 2005) . Although different types of dementia exist, Alzheimer's disease (AD) and vascular dementia (VaD) are the most prevalent types (Wiesmann et al., 2013) . A meta-analysis performed on 28 studies suggests that diabetic patients face increased risk of AD by 56% and VaD by 127% (Gudala et al., 2013) .
The key pathological events in AD brain involve deposition of amyloid beta (Aβ), a 36-43 amino acid peptide that accumulates extracellularly as plaques, and hyperphosphorylated tau (p-tau), a microtubule protein that intracellularly accumulates as neurofibrillary tangles (NFTs) (Takashima et al., 1998) . Various mechanisms have been proposed previously whereby diabetes might influence the development of dementia by accelerating the pathological events. However, these studies are controversial. Some reports suggest that patients with diabetes have high Aβ plaques and NFT depositions (Janson et al., 2004; Peila et al., 2002) , while others suggest no association or inverse relationship (Arvanitakis et al., 2006) . Notably, some studies indicated a greater role of cellular prion protein (PrP reviewed that there is strong evidence stating that diabetes mellitus increases the risk of cognitive impairment and dementia (Saedi et al., 2016) . In a cohort study 1291 participants with type-2 diabetes from the Fremantle Diabetes Study and 5159 matched residents were documented (Davis et al., 2016) . The study concluded that type-2 diabetes is associated with increased incidence of dementia.
MicroRNAs (miRNAs, miRs), a class of small non-coding RNAs, have been studied to play various functions in cerebrovascular complications as well as dementia (Kalani et al., 2014b; Maes et al., 2009) . Recently, a study with deep sequencing of exosomes released from prion-infected neuronal cells revealed distinct miRNA signatures as compared to non-infected cells (Bellingham et al., 2012) , suggesting the potential role of miRNAs over prion regulation. However, the role of miRNAs in memory loss related to prion in diabetes is not well studied. In this study we combined the therapeutic effects of exosomes and miR-146a to deliver in db/db mice T2D brains and evaluated the PrPc levels and cognitive function. Exosomes, a subpopulation of micro-vesicles ranging 40-100 nm, have enormous potential to deliver therapeutic drugs, nucleic acids, and functional proteins (Haney et al., 2015; Kalani et al., 2014c) . These nano-units can easily cross biological barriers, preserve mRNA and miRNAs, and deliver functional RNAs to the distal targets in the brain (Alvarez-Erviti et al., 2011; Kalani et al., 2014a; Valadi et al., 2007; Zomer et al., 2010) . In this regard, exosomes can be a superior choice over other delivery vehicles for cerebral complications; though, more studies are still required to prove their suitability for the efficient molecular delivery and brain therapeutics.
In the current study, two aspects of T2D dementia-like factors were addressed: 1) We identified the miRNA which can regulate PrP c expression in dementia-like pathology; and 2) We explored the feasibility of using brain endothelial cell derived exosomes (BECDEs) to deliver miRNA to reduce PrP c and memory loss. Studies were performed using obese T2D db/db (leptin receptor knockout) mice that demonstrate hyperglycaemia, hyperinsulinemia, cerebro-vascular complications, AD and VaD pathology (Ramos-Rodriguez et al., 2013) .
Materials and methods

Animals
All animal procedures were carefully reviewed and approved by the Institutional Animal Care and Use Committee, University of Louisville, in accordance with the animal care and guidelines of the National Institutes of Health. 12-14 weeks old mice were used for the experiments. The study groups consisted of: 1) obese male T2D db/db mice with background strain C57BL/KsJ (BKS·Cg-Dock7m +/+ Lepr db /J), and 2) lean age-matched non-diabetic (db/m) control mice. Mice were purchased from Jackson Laboratories (Bar Harbor, ME, USA) and they were maintained on a 12 h light/dark cycle with free access to food and water.
Novel object recognition test
The test was performed as published in our earlier report (Muradashvili et al., 2014) , with some modifications. Briefly, the mice were acclimatized with familial objects two times a day for 3 days and an hour before the test. At the time of test, one of the old objects was changed with novel object and mouse tracking was performed for 5 min using a Top Scan behavioral analyzing system (Version 3.00 by CleverSys; Reston, VA, USA). The following formulas were used to calculate short-term memory: 1) Recognition Index = Novel object / novel object + old object; 2) Discrimination index = Novel object-old object / novel object + old object; 3) Preference Index = Novel object / novel object + old object × 100.
Y-maze test
Animals were acclimatized for 2 days, twice per day, for 10 min and then tested on Y-maze for determining spontaneous behaviour alterations. The test was performed for 8 min and the number of arm entries was counted when all four limbs of the mouse were within the arm. The number of triads (sequence of three consecutive visits to different arms) was recorded in order to calculate the percentage of spontaneous alternations according to the formula: Spontaneous alterations (%) = total number of triads / total number of arm entries-2 × 100.
BECDEs isolation, characterization, loading with miR-146a mimic and delivery
BECDEs were isolated from mouse brain endothelial cell line (bEnd.3) as described previously (Kalani et al., 2014a) (Kalani et al., 2016) with some modifications. Briefly, bEnd.3 cell culture conditioned media was ultracentrifuged at 1,40,000 ×g at 4°C for 3 h after following two centrifugations at 3000 ×g and 10,000 ×g, respectively. The pellet obtained after ultracentrifugation was used as BECDEs source. BECDEs particle size and concentration was measured using the ZetaView PMX 110 nanoparticle tracking analysis (NTA) system (Particle Metrix, Meerbusch, Germany) and corresponding software ZetaView 8.02.31. The ZetaView system was calibrated using 100 nm polystyrene particles and the temperature was maintained~25°C. BECDEs were loaded with miR-146a mimic or scramble mimic (Qiagen) using chemical transfection method (101 Bio, Palo Alto, CA, USA) as described by manufacture's protocol. The excess of micelles, salts and short nucleotides were removed by spin columns (MW 3000, ThermoFisher Scientific, Grand Island, NY, USA). To visualize BECDEs in tissue sections they were labelled with lipophilic, carbocyanine fluorescent dye (Invitrogen), as described by manufacturer's instructions. Alexa fluor 647-labelled miRNA was loaded in pre-labelled BECDEs and processed similarly as described above. The procedure of intracerebroventricular (i.c.v.) delivery was performed as described earlier (Kalani et al., 2014b) . BECDEs loaded with miR-146a or scramble mimic were injected into the brain via. i.c.v. route (2-3 μg, once a day for 3 successive days). As described previously (Kalani et al., 2014a; Sokolova et al., 2011) , Western blot using anti-tumor susceptibility gene101 (TSG101) antibody and activity assay for acetylcholinesterase (AchE) was used to characterize BECDEs integrity after miR-146a transfection.
Collection of brain samples
At the end of experiments mice were euthanized. Brain tissue samples were harvested, stored properly for Western blot, quantitative PCR (QPCR) and Immunohistochemistry analysis.
SDS-PAGE and Western blotting
Equal quantities of mice brain extracts (25 μg) were separated on polyacrylamide gel under reducing condition and transferred to polyvinyldifluoride membrane using an electrotransfer apparatus (Bio-Rad, Hercules, CA, USA). After blocking with 5% non-fat dry milk for 1 h, the membranes were probed with a primary antibody overnight at 4°C (PrP c , Sigma, 1:500; Glycogen synthase kinase-3 (GSK-3), Abcam, 1: 500; Microtubule-associated protein-2 (MAP-2), Abcam, 1:500; tau, Abcam, 1:1000; and, phospho-tau, Abcam, 1:1000). Next day, the membranes were probed with the appropriate secondary antibody (Santa cruz, 1:5000) for 1 h at room temperature and then developed using a Bio-Rad Molecular Imager (ChemiDoc XRS+, Hercules, CA, USA).
Quantitative gene expression analysis
Total RNA from the brain tissue was isolated using miRNeasy Kit (Qiagen, Valencia, CA, USA) and converted to cDNA using miScript II RT kit (Qiagen), as per manufacturer's instructions. The cDNA samples were amplified for determining different miRNAs expressions in a 96 well format RT 2 -qPCR array (MIMM-107ZA-2, Mouse Neurologic Development and Disease, Qiagen) using miScript SYBR Green PCR kit (Qiagen). The cDNA samples were also analyzed for individual miRNAs expression (miR-146a, snoRD72 and RNU-6) (Qiagen). The amplification was performed in Stratagene Mx3000p (Agilent Technologies, Santa Clara, CA) and the cycle threshold (CT) values were determined after baseline and threshold adjustments. For the analysis, baseline and threshold adjustments were kept constant for all the experiments and the results were expressed as fold expression. The altered miRNAs (up-regulated or down-regulated) were checked for sequence similarity to PrP c by an online software targetscan provided by Whitehead institute for the targets of miRNAs (http://www.targetscan.org/).
Immunohistochemistry
At the completion of experiments, mice were deeply anesthetized with an overdose of anesthesia and infused with tetramethylrhodamine β-isothiocyanate (TRITC) -conjugated lycopersicon esculentum agglutinin (LEA) tomato lectin (Vector Laboratories, Burlingame, CA, USA) via a cannula in the carotid artery. Animals were euthanized via exsanguination by infusing transcardiacally a 50 mM phosphate buffer saline (PBS) solution. The cranium was carefully opened and the brain was carefully removed. The brain was mounted in a protective (OCT) matrix (Polyscience, Inc., Warrington, PA, USA) and cryo-sectioned using a Leica CM 1850 cryostat (Bannockburn, IL, USA). Frozen brain blocks were cut into 25 μm sections using a cryostat (Leica CM, USA) and fixed in ice-cold methanol for 10 min. The tissues were blocked with blocking solution [0.1% Triton X-100 TBS (TBS-T), 0.5% BSA, and 10% normal donkey serum] for 1 h at room temperature. The sections were incubated with primary antibody for PrP c (Sigma, 1:150), and phospho-tau (Abcam, 1:200) overnight at 4°C. After incubation with appropriate fluorescence secondary antibodies (1:300) (alexa fluor, Invitrogen, Grand Island, NY) for 60 min at room temperature, the sections were stained with 4′, 6-diamidino-2-phenylindole (DAPI, 1:10,000), and mounted with anti-fade mounting media. Images were acquired using a laser scanning confocal microscope (FluoView 1000; Olympus, PA, USA) and the data was analyzed with image analysis software (Image-Pro Plus).
Statistical analysis
Statistical comparisons between two groups were performed using unpaired Student's t-test. One way ANOVA was used to compare effects of miRNA treatments between groups and post-hoc pairwise comparisons were performed using Tukey's test. P value of b0.05 was considered to be statistically significant. All values are expressed as mean ± standard error of the mean (SEM), unless otherwise stated. Fig. 1A shows representative images of tracked mice (db/m control and T2D db/db) for their interest in a novel object to evaluate shortterm memory. T2D db/db mice showed loss of short-term memory as determined by the recognition index (Fig. 1B) , the discrimination index (Fig. 1C) , and the preference index (Fig. 1D) , as compared to db/ m controls. Y-maze test (Fig. 1E ) was used to evaluate alterations in spontaneous behaviour by analyzing the exploratory behaviour of mice. The analysis demonstrated that T2D db/db mice had significantly more alterations in spontaneous behaviour as compared to db/m controls (Fig. 1F) .
Results
T2D db/db mice have impaired memory
T2D db/db mice brains exhibited disrupted microtubule associated proteins
Western blot analysis exemplified decreased protein expression of GSK-3 in the brain of T2D db/db mice as compared to db/m controls ( Fig. 2A and B) . Western blot analysis also showed reduced expression of microtubule associated proteins (MAP-2 and tau) and increased expression of phosphorylated tau (P-tau) in T2D db/db mice, as compared to db/m controls (Fig. 2C and D) . The brain ratio of phosphorylated tau to total tau was found to be highly increased in T2D db/db mice as compared to db/m controls (Fig. 2E) . Immunohistochemistry analysis of brain coronal sections also exhibited increased tau phosphorylation in T2D db/db mice as compared to db/m controls ( Fig. 2F and G) .
T2D db/db mice showed altered regulations of miRNAs
Using qRT
2 -PCR array, we determined that in brains of T2D db/db mice 16 miRNAs were upregulated and 2 were downregulated (miR146a, miR-133b), as compared to db/m mice (Fig. 3A) . Bioinformatics analysis using targetscan revealed that only miR-146a sequence recognized the 87-93 bp of the conserved sequence of PrP c (Fig. 3B) . 
T2D db/db mice showed induced expression of prion
Western blot analysis determined that brains of T2D db/db mice had increased PrP c expression as compared to db/m controls ( Fig. 4A and B) .
Furthermore, IHC analysis demonstrated a significant increase in fluorescence intensity of PrP c around brain vessels of T2D db/db mice as compared to db/m controls ( Fig. 4C and D) .
BECDEs characterization, transfection with miRNA and intracerebroventricular delivery
NTA analysis determined the size of BECDEs to be 108.4 ± 49.8 nm (Fig. 5A, B and C) . Brain coronal sections of T2D db/db mice showed the presence of BECDEs-loaded with alexa fluor-647 around brain blood vessels and cortical areas ( Fig. 5D and E) , confirming successful i.c.v. delivery of miRNA through BECDEs. Further, BECDEs transfected with miR-146a showed specific band of TSG101 on Western blot and AchE activity similar to un-transfected BECDEs, confirming the integrity of BECDEs after transfection ( Fig. 5F and G) .
Effect of miR146a-loaded BECDEs administration on PrP c expression
and memory restoration in T2D db/db mice QPCR analysis further confirmed an increase in miR-146a in T2D db/ db mice treated with miR146a-loaded BECDEs as compared to db/m mice treated with scramble (scr) miRNA-loaded BECDEs (Fig. 6A) . Furthermore, protein expression analysis using Western blots determined that brains of T2D db/db mice had reduced expression levels of PrP c when treated with miR146a-loaded BECDEs as compared to T2D db/ db mice treated with scramble-loaded BECDEs (Fig. 6B and C) . Administration of T2D db/db mice with miR146a-loaded BECDEs compared to T2D db/db mice receiving scramble-loaded BECDEs did not show an improvement in short-term memory (Fig. 6D) . The recognition index was not statistically different (P = 0.0617), but it was trending toward significance.
Discussion
Although the association between diabetes and dementia is controversial, many reports provide evidence that diabetes may influence underlying pathologies associated with dementia (Gispen and Biessels, 2000) . However, clear mechanistic studies are still lacking. Our study using obese T2D db/db mice is an attempt to better understand the underlying mechanisms for diabetes-associated dementia since these mice have been documented to develop hyperglycemia, hyperinsulinemia, cerebro-vascular complications, AD-, and VaD-associated pathology (Ramos-Rodriguez et al., 2013) . The obese db/db mice models resemble the pathology developed in type-2 diabetic humans and our study using different behavioral tests suggest that these mice have impaired shortterm memory function related to the recognition of a novel object and related to their normal exploratory behaviour in a Y-maze test. Our study provided evidence that 12-14 weeks old T2D db/db mice exhibited abnormal exploratory behaviour and short-term memory loss as compared to non-diabetic db/m controls. PrP c expression was upregulated and GSK-3 expression was downregulated in the brains of T2D db/db diabetic mice as compared to db/m controls. GSK-3 is a key signalling molecule for memory function (Takashima et al., 1998) . Also, brains from T2D mice exhibited disrupted microtubule associated proteins including reduced expression of microtubule associated proteins MAP-2 and tau. Tau phosphorylation along with Aβ tangles are important mediators of neurotoxicity and are associated with cognitive deficits (Nisbet et al., 2015) . Interestingly, all the above protein anomalies are considered hall marks of dementia-associated pathology. Development of therapies to treat diabetes-associated pathology in the brain requires a better understanding of the underlying mechanisms. One approach is based on the work developed by Poy et al. (2004) regarding the role of miRNAs in type-2 diabetes and its related complications (Kantharidis et al., 2011 ). Poy's group identified miR-375 as playing a key role in insulin secretion, and this work spurred new miRNA associated research in type-2 diabetes including the present work. During our search for candidate miRNAs in the T2D db/db brain, we found that several miRNAs were upregulated and only two were downregulated using microRNA array. After matching miRNAs with genes through mirbase/targetscan, miR-146a was identified to match PrP c which is a known protein in dementia like pathology. In 12-14 weeks old T2D db/db brains we found that the PrPc is upregulated as compared to controls. Recent studies have determined that PrP c can play important role in Aβ deposition, and therefore, it could serve as a prime target for therapies treating cognitive impairment (Chung et al., 2010; Gimbel et al., 2010) . Studies from our lab using a traumatic brain injury model in mice (Muradashvili et al., 2015) demonstrates the importance of PrP c in memory loss. The high affinity of Aβ and tau for PrP c in the formation of oligomeric complexes underscores the apparent role of PrP c in cognitive decline that can eventually lead to severe dementia. Interestingly we found upregulated PrPc only in old mice (12-14 week) and not in young mice (8 weeks), which is in agreement with the fact that dementia-like pathology is most commonly age related.
To establish whether PrP c plays a regulatory role in memory, we increased miR-146a levels in T2D db/db brains by loading a miR-146a into BECDEs and these were later administered into one of the brain's ventricles. Exosomal delivery of therapeutic agents is rapidly gaining popularity because they are small, non-immunogenic and can cross cellular barriers while retaining therapeutic molecules (Kalani et al., 2014c ) (Valadi et al., 2007) . Exosomes deliver their cargo to target cells by a variety of mechanisms including: fusion, endocytosis, micropinocytosis, and phagocytosis (Marcus and Leonard, 2013) . Through confocal studies, we were able to confirm that labelled-exosomal BECDEs loaded with labelled-miRNAs, reached targeted brain cells. Furthermore, in T2D db/db mice receiving miR-146a loaded BECDEs, miR-146a induced a 4 to 5 fold increase in miR-146a transcript levels and also reduced PrP c levels by 1.6 to 2 fold compared to those treated with scramble miRNA loaded BECDEs. The functional efficacy of RNA transfer between the cells via exosomes has been shown in several reports (Valadi et al., 2007) . We found improvement of short-term memory function in T2D db/db mice treated with miR146a-loaded BECDEs though it was not significant and further studies are warranted with increased sample size. Although increase in PrPc leads to dementia-like pathology the reverse may not be true. Apart from PrPc that contribute to dementia like pathology, there are additional contributory pathways that involve the phosphorylation of tau and signalling molecules, which are well known to mediate pathology. Endoplasmic reticulum stress is another pathway that can contribute to development of diabetes and dementia-like pathology. Ivask et al. have demonstrated that mutation in the WFS gene that encodes an endoplasmic reticulum resident transmembrane protein leads to the development of ER stress and juvenile diabetes which increases high risk of dementia like pathology (Ivask et al., 2016) . The WFS gene is also important in the development of diabetes earlier in males than female (Noormets et al., 2011) . Our working hypothesis is presented in Fig. 7 . To conclude, our results suggest that type-2 diabetes may promote induction of pathological events (tau-phosphorylation and PrP c upregulation) which results in behavioral alterations including: short-term memory loss and abrupt exploratory behaviour. Exosomal-based therapy with a miR-146a attenuates PrP c upregulation and improves cognitive functions which suggest that early intervention can postpone the onset of cognitive dysfunction. Therefore, additional studies are needed to further investigate age related memory loss in different age groups of mice with larger sample sizes. Also, efforts are needed to optimize the methods of miRNA loading to exosomes and delivering different concentrations of miRNAs to get optimized results.
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